Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196) appointed Huang Zhi as chief financial officer, according to a Friday disclosure on the Shanghai bourse.
Huang, who was also appointed as senior vice president, will take over from Chen Zhanyu, who resigned due to adjustments in work arrangements.